Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.

about

Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.

Item

http://www.wikidata.org/entity/Q42036230

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@en

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@nl

type

Item

label

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@en

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@nl

prefLabel

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@en

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@nl

P1476

Thrombotic thrombocytopenic pu ...... sfully treated with rituximab.

@en

P2093

Jen C Wang

http://www.w3.org/2001/XMLSchema#string

Nishant Poddar

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura.

Immune-mediated complications during interferon therapy in hematological patients.

Vascular events associated with alpha interferon therapy.

Recent advances in thrombotic thrombocytopenic purpura.

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature.

Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C.

Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.

[Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C].

P304

5-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4081/HR.2013.E2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

252325843

http://www.w3.org/2001/XMLSchema#string

P698

23888238

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

3719105

http://www.w3.org/2001/XMLSchema#string